mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.5 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
-0.022 |
0.5 |